Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01877096 · ClinicalTrials.gov registry record · NA

Motivational Interviewing for Colonoscopy

A NA study of Colorectal Cancer, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT01877096: Completed NA study of Colorectal Cancer, sponsored by Icahn School of Medicine at Mount Sinai.

NCT01877096 is a NA study of Colorectal Cancer that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 57 participants, below the 1,545-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01877096, a NA study of Colorectal Cancer, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to begin to examine the efficacy of a motivational interviewing intervention to increase African Americans' screening colonoscopy rates. The results from this pilot study will allow us to estimate the magnitude of the intervention and mediation effect sizes.

Primary Outcome

Medical chart review will be conducted 6 months after the primary care appointment in which the participants received a referral for a screening colonoscopy

Conditions Studied

Interventions

  • BEHAVIORAL Attention Control
  • BEHAVIORAL Motivational Interviewing

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2013-08
Est. Completion 2014-02
Phase NA

What the finished NCT01877096 record still lists

NCT01877096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,545-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.

NCT01877096 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01877096 about?

NCT01877096 is a clinical study titled "Motivational Interviewing for Colonoscopy". The purpose of this study is to begin to examine the efficacy of a motivational interviewing intervention to increase African Americans' screening colonoscopy rates. The results from this pilot study will allow us to estimate the magnitude of the intervention and mediation effect sizes.

What is the current status of trial NCT01877096?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2013-08. Estimated completion is 2014-02.

What conditions does trial NCT01877096 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT01877096?

The interventions under investigation include: Attention Control (BEHAVIORAL), Motivational Interviewing (BEHAVIORAL).

Who is sponsoring clinical trial NCT01877096?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01877096 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01877096's enrollment target sits among peer trials

57 262nd of 381 higher than 119 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03521830 · 57 participants · Phase 2

    Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

  • NCT03587701 · 57 participants · Phase 2

    Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

  • NCT04104126 · 57 participants · NA

    Blood Flow Restriction Therapy in Achilles Injury

  • NCT04703842 · 57 participants · Phase 1

    Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01877096, the US trial registry maintained by the National Library of Medicine. NCT01877096 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.